Stiles Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Buy |
4,358
+262
| +6% | +$138K | 0.79% | 46 |
|
|
2025
Q1 | $2.6M | Buy |
4,096
+200
| +5% | +$127K | 1% | 29 |
|
|
2024
Q4 | $2.77M | Buy |
3,896
+464
| +14% | +$330K | 1% | 29 |
|
|
2024
Q3 | $3.61M | Buy |
3,432
+89
| +3% | +$93.5K | 1.27% | 17 |
|
|
2024
Q2 | $3.51M | Buy |
3,343
+64
| +2% | +$67.2K | 1.35% | 16 |
|
|
2024
Q1 | $3.16M | Buy |
3,279
+246
| +8% | +$237K | 1.26% | 18 |
|
|
2023
Q4 | $2.66M | Buy |
3,033
+334
| +12% | +$293K | 1.21% | 25 |
|
|
2023
Q3 | $2.22M | Buy |
2,699
+753
| +39% | +$620K | 1.15% | 21 |
|
|
2023
Q2 | $1.4M | Buy |
1,946
+571
| +42% | +$410K | 0.69% | 48 |
|
|
2023
Q1 | $1.13M | Buy |
1,375
+385
| +39% | +$316K | 0.61% | 54 |
|
|
2022
Q4 | $714K | Buy |
+990
| New | +$714K | 0.41% | 71 |
|